Tags: hemophilia | N9-GP | uncontrollable bleeding | new drugs

New Hemophilia Drug Stops Bleeding With One Treatment

Friday, 17 May 2013 12:16 PM

 
Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP.
 
Novo Nordisk said in a statement that in patients given the drug, 99 percent of bleeding episodes were treated with only one infusion and two-thirds of the patients had experienced complete resolution of bleeding.
 
Patients had also reported an improvement in quality of life during the trial and the drug appeared to have a safe and well-tolerated profile, Novo said in the statement.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP. Novo Nordisk said in a statement that in patients given the drug, 99 percent of bleeding episodes were treated with only...
hemophilia,N9-GP,uncontrollable bleeding,new drugs
88
2013-16-17
Friday, 17 May 2013 12:16 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved